Jamie L. Reynoso - 16 Jul 2021 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role
Chief Operating Officer
Signature
/s/ Gia Lee, as Attorney-in-Fact
Issuer symbol
CLOV
Transactions as of
16 Jul 2021
Net transactions value
$0
Form type
4
Filing time
20 Jul 2021, 21:50:57 UTC
Next filing
26 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Award $0 +220,820 $0.000000 220,820 16 Jul 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in equal annual installments over four years, beginning on January 7, 2022, subject to the continuous service of the Reporting Person on each vesting date.